Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE10.2600
- TODAY'S CHANGE (%)-0.0400 (-0.3883%)
- Bid / Lots9.6300/ 1
- Ask / Lots11.0000/ 47
- Open / Previous Close10.1000 / 10.3000
- Day Range
- 52 Week Range
- Volume304,923
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 4969 | 10.165 |
| 09:33 ET | 382 | 10.06 |
| 09:37 ET | 1637 | 10.3 |
| 09:39 ET | 440 | 10.36 |
| 09:46 ET | 100 | 10.31 |
| 09:48 ET | 1700 | 10.3 |
| 09:50 ET | 100 | 10.26 |
| 09:53 ET | 500 | 10.255 |
| 09:55 ET | 668 | 10.25 |
| 10:00 ET | 200 | 10.3 |
| 10:02 ET | 200 | 10.315 |
| 10:04 ET | 2153 | 10.35 |
| 10:09 ET | 218 | 10.33 |
| 10:13 ET | 6486 | 10.3 |
| 10:15 ET | 527 | 10.33 |
| 10:20 ET | 800 | 10.25 |
| 10:26 ET | 600 | 10.24 |
| 10:27 ET | 620 | 10.25 |
| 10:31 ET | 527 | 10.21 |
| 10:33 ET | 2728 | 10.22 |
| 10:36 ET | 300 | 10.265 |
| 10:38 ET | 285 | 10.26 |
| 10:42 ET | 1301 | 10.23 |
| 10:44 ET | 2776 | 10.25 |
| 10:47 ET | 711 | 10.25 |
| 10:49 ET | 1212 | 10.265 |
| 10:51 ET | 300 | 10.27 |
| 10:54 ET | 100 | 10.26 |
| 10:56 ET | 100 | 10.25 |
| 11:00 ET | 664 | 10.25 |
| 11:02 ET | 862 | 10.25 |
| 11:03 ET | 200 | 10.25 |
| 11:05 ET | 500 | 10.28 |
| 11:07 ET | 1160 | 10.24 |
| 11:09 ET | 100 | 10.22 |
| 11:12 ET | 2039 | 10.205 |
| 11:14 ET | 607 | 10.22 |
| 11:20 ET | 601 | 10.24 |
| 11:21 ET | 500 | 10.26 |
| 11:23 ET | 600 | 10.245 |
| 11:32 ET | 200 | 10.28 |
| 11:34 ET | 100 | 10.27 |
| 11:36 ET | 310 | 10.24 |
| 11:38 ET | 253 | 10.25 |
| 11:39 ET | 100 | 10.25 |
| 11:41 ET | 397 | 10.24 |
| 11:43 ET | 300 | 10.22 |
| 11:45 ET | 647 | 10.215 |
| 11:48 ET | 100 | 10.215 |
| 11:50 ET | 900 | 10.24 |
| 11:52 ET | 100 | 10.24 |
| 11:54 ET | 1632 | 10.26 |
| 11:56 ET | 100 | 10.26 |
| 11:57 ET | 1090 | 10.255 |
| 11:59 ET | 355 | 10.22 |
| 12:01 ET | 200 | 10.22 |
| 12:06 ET | 299 | 10.205 |
| 12:10 ET | 200 | 10.22 |
| 12:12 ET | 398 | 10.205 |
| 12:14 ET | 4104 | 10.21 |
| 12:15 ET | 300 | 10.21 |
| 12:17 ET | 200 | 10.19 |
| 12:19 ET | 1172 | 10.2 |
| 12:21 ET | 357 | 10.18 |
| 12:24 ET | 557 | 10.14 |
| 12:26 ET | 335 | 10.19 |
| 12:28 ET | 400 | 10.19 |
| 12:30 ET | 444 | 10.22 |
| 12:32 ET | 100 | 10.22 |
| 12:35 ET | 566 | 10.23 |
| 12:37 ET | 740 | 10.24 |
| 12:39 ET | 692 | 10.24 |
| 12:42 ET | 200 | 10.23 |
| 12:44 ET | 900 | 10.22 |
| 12:46 ET | 550 | 10.215 |
| 12:48 ET | 100 | 10.22 |
| 12:50 ET | 300 | 10.22 |
| 12:53 ET | 1193 | 10.22 |
| 12:55 ET | 3187 | 10.22 |
| 12:57 ET | 854 | 10.22 |
| 01:00 ET | 2504 | 10.21 |
| 01:04 ET | 1031 | 10.22 |
| 01:06 ET | 400 | 10.255 |
| 01:11 ET | 100 | 10.245 |
| 01:13 ET | 1017 | 10.24 |
| 01:15 ET | 500 | 10.26 |
| 01:18 ET | 1056 | 10.26 |
| 01:20 ET | 402 | 10.26 |
| 01:24 ET | 18520 | 10.205 |
| 01:27 ET | 789 | 10.25 |
| 01:31 ET | 100 | 10.22 |
| 01:36 ET | 1464 | 10.28 |
| 01:38 ET | 400 | 10.265 |
| 01:40 ET | 358 | 10.24 |
| 01:42 ET | 100 | 10.25 |
| 01:44 ET | 100 | 10.25 |
| 01:49 ET | 400 | 10.25 |
| 01:51 ET | 429 | 10.26 |
| 01:54 ET | 400 | 10.25 |
| 02:00 ET | 200 | 10.25 |
| 02:02 ET | 600 | 10.29 |
| 02:05 ET | 200 | 10.27 |
| 02:07 ET | 200 | 10.265 |
| 02:12 ET | 134 | 10.245 |
| 02:14 ET | 200 | 10.25 |
| 02:18 ET | 450 | 10.26 |
| 02:20 ET | 100 | 10.26 |
| 02:21 ET | 400 | 10.28 |
| 02:23 ET | 100 | 10.275 |
| 02:25 ET | 155 | 10.29 |
| 02:27 ET | 400 | 10.33 |
| 02:30 ET | 200 | 10.3 |
| 02:38 ET | 100 | 10.3 |
| 02:41 ET | 1542 | 10.31 |
| 02:45 ET | 500 | 10.3 |
| 02:48 ET | 300 | 10.28 |
| 02:50 ET | 200 | 10.29 |
| 02:54 ET | 500 | 10.26 |
| 02:56 ET | 218 | 10.26 |
| 02:57 ET | 400 | 10.24 |
| 03:01 ET | 1825 | 10.25 |
| 03:03 ET | 500 | 10.24 |
| 03:06 ET | 700 | 10.26 |
| 03:10 ET | 741 | 10.25 |
| 03:12 ET | 100 | 10.25 |
| 03:14 ET | 600 | 10.26 |
| 03:15 ET | 200 | 10.25 |
| 03:17 ET | 638 | 10.255 |
| 03:19 ET | 1100 | 10.26 |
| 03:21 ET | 200 | 10.26 |
| 03:24 ET | 445 | 10.245 |
| 03:26 ET | 390 | 10.25 |
| 03:28 ET | 1202 | 10.2125 |
| 03:30 ET | 300 | 10.23 |
| 03:32 ET | 244 | 10.23 |
| 03:33 ET | 400 | 10.215 |
| 03:35 ET | 300 | 10.23 |
| 03:37 ET | 100 | 10.23 |
| 03:39 ET | 100 | 10.23 |
| 03:42 ET | 600 | 10.24 |
| 03:44 ET | 1679 | 10.25 |
| 03:46 ET | 2034 | 10.29 |
| 03:48 ET | 600 | 10.305 |
| 03:50 ET | 1525 | 10.315 |
| 03:51 ET | 1400 | 10.261 |
| 03:53 ET | 2203 | 10.25 |
| 03:55 ET | 1600 | 10.28 |
| 03:57 ET | 2513 | 10.235 |
| 04:00 ET | 67219 | 10.26 |
Today
Nov 4, 2024
ORIC(R) Pharmaceuticals to Participate in Upcoming Investor Conferences, from 4:15PM ET on Monday Nov 04, 2024 by Dow Jones
4:15PM ET on Monday Nov 04, 2024 by Dow JonesDJ Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 7:04AM ET on Monday Nov 04, 2024 by Dow Jones
7:04AM ET on Monday Nov 04, 2024 by Dow Jones
Nov 1, 2024
ORIC(R) Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Nov 01, 2024 by Dow Jones
4:30PM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 726.6M | -5.8x | --- |
Tourmaline Bio Inc | 726.2M | -15.6x | --- |
Olema Pharmaceuticals Inc | 728.4M | -5.6x | --- |
Annexon Inc | 736.4M | -5.4x | --- |
Mineralys Therapeutics Inc | 741.9M | -4.9x | --- |
Perspective Therapeutics Inc | 747.8M | -7.7x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $726.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.14 |
EPS | $-1.76 |
Book Value | $4.08 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
